The Northwell Kidney Transplant Program Is Nation’s Best In 2 Survival Metrics

The Northwell Transplant Institute at North Shore University Hospital (NSUH) has been rated the nation’s No. 1 adult kidney transplant program in two key survival metrics, according to new data from the Scientific Registry of Transplant Recipients (SRTR).

NSUH, which completed 195 adult kidney transplants in 2023, is ranked best in the nation for 90-day patient survival. This ranking is based on the hospital’s hazard ratio of 0.35 for the 322 transplants performed between January 1, 2021 and June 30, 2023. NSUH was tops among the 215 hospital programs that perform adult kidney transplants nationally.

In addition, NSUH’s living donor transplant survival rate is best in the U.S., with 100 percent kidney function three years after transplant. Northwell’s overall three-year patient survival hazard ratio for all adult kidney transplants is 0.46, which is among the top 5 percent of U.S. programs and the best in New York State.

“This SRTR report reflects the outstanding care delivered at the Northwell Transplant Institute,” said Nabil Dagher, MD, vice president and director of the Northwell Transplant Institute, “Our entire transplant team is dedicated to helping our patients heal and get back to their best lives.”

The SRTR provides solid organ transplant data in the United States under license from the Health Resources and Services Administration and U.S. Department of Health and Human Services. More than 46,000 organ transplants were performed in 2023, nearly 28,000 of them kidneys, both record highs in the U.S. There were 90,000 people awaiting a kidney transplant during that period.

“Getting a transplant quickly is important, but equally important is making sure the transplant lasts,” said Vinay Nair, DO, medical director of the adult kidney transplant program at the Northwell Transplant Institute. “Having a short time to transplant coupled with some of the best 3-year outcomes in the nation is a testament to the success of our center.”

“A kidney transplant is the gold standard of care for individuals with kidney failure. Transplantation requires a multidisciplinary approach and a dedicated team of transplant professionals,” said Niraj Desai, MD, surgical director of the kidney transplant program at the Northwell Transplant Institute. “We are proud to serve the world’s most diverse population and provide equitable access to care. No one does it better – the evaluation, surgery, postoperative care and long term follow up – than the Northwell Transplant Institute.”

Northwell started performing adult kidney transplants at NSUH in 2007 and established its pediatric kidney transplant program at Cohen Children’s Medical Center in New Hyde Park in 2017. Today, NSUH offers comprehensive solid organ transplantation services for adult heart, kidney, liver and lung.

For more information or to book an appointment, call 516-472-5800 or go to: https://nsuh.northwell.edu/transplant-center/contact-us

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”